Update on nonallergic rhinitis (Q34265991)

1 August 2017

1 reference

title

Update on nonallergic rhinitis (English)

1 reference

1 August 2017

Settipane RA

1

1 reference

PubMed ID

11379801

1 August 2017

Lieberman P

series ordinal

2

1 reference

1 August 2017

1 May 2001

1 reference

Annals of Allergy, Asthma & Immunology

1 August 2017

1 reference

1 August 2017

86

1 reference

1 August 2017

5

1 reference

1 August 2017

494-507; quiz 507-8

1 reference

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Allergic and nonallergic rhinitis: Their characterization with attention to the meaning of nasal eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects☆☆☆★Results from the European Community Respiratory Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Nasal methacholine challenge. A test for the measurement of nasal reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Goblet cell density of the inferior turbinates in patients with perennial allergic and nonallergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

The inferior turbinate mast cell population of patients with perennial allergic and nonallergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Effect of steroids on nasal inflammatory cells and cytokine profile

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Product characteristics and pharmacokinetics of intranasal ipratropium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Endoscopic transseptal vidian neurectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Bilateral transnasal vidian neurectomy in the management of chronic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Vasomotor rhinitis and sphenopalatine ganglion block

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

The effect of purified human eosinophil major basic protein on mammalian ciliary activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Epithelial injury by human eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Clinical and nasal biopsy response to treatment of perennial rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

1 reference

7 January 2021

Chronic sinusitis: characterization of cellular influx and inflammatory mediators in sinus lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

The human respiratory nasal mucosa in pregnancy. An electron microscopic and histochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Asymptomatic nasal septal perforations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Abnormalities of taste and smell in Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

The pathophysiology and treatment of rhinitis medicamentosa

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Edward Woakes: the history of an eponym

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Polypoidal rhinosinusitis in cystic fibrosis: a clinical and histopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

IL-5 synthesis is upregulated in human nasal polyp tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Histamine, norepinephrine and serotonin content of nasal polyps

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Immunopathology of nasal polypi

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Nasal polyps: effects of seasonal allergen exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Magnetic resonance cisternography and thin coronal computerized tomography in the evaluation of cerebrospinal fluid rhinorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

The ozena problem. Clinical analysis of atrophic rhinitis in 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Cigarette smoke induced pathology of the rat respiratory tract: a comparison of the effects of the particulate and vapour phases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Neutrophil influx measured in nasal lavages of humans exposed to ozone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

Occupational formaldehyde exposure and increased nasal cancer risk in man

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962896-7

7 January 2021

10.1016/S1081-1206(10)62896-7

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11379801